Lost Children Society (LCS), Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients (TTRPG)

Lost Children Society (LCS), Metacognitive Training Integrated Into an Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients : a Pilot Study on Feasibility

The Lost Children Society (LCS) is a Therapeutic TableTop Role-Playing Game specifically developed for early-onset schizophrenia patient.

It is performed online via a secure teleconsultation and videoconference platform.

Patients are connected from their home, on their personal computer or tablet, equipped with headsets with microphone.

This study aims to validate the feasibility of this online Therapeutic TableTop Role Playing Game.

Study Overview

• Status: Withdrawn
• Conditions: Schizophrenia
• Intervention / Treatment: Behavioral: Lost Children Society Game

• Study Type: Interventional
• Phase: Not Applicable

Contacts and Locations

Study Locations

• France
  • Colombes, France
    • Hôpital Louis Mourier
  • La Roche-sur-Yon, France
    • Centre Hospitalier Georges Mazurelle
  • Nantes, France
    • Centre Hospitalier Universitaire

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 15 years to 20 years (Child, Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Diagnosis of early onset schizophrenia
• Patient who has the capacity to understand the protocol and to perform evaluations
• Written informed consent to participate in the study given by the patient or by the parental authority of the minor patient.
• Patient with social security coverage

Exclusion Criteria:

• Intelligence quotient<70 on Wechsler Adults Intelligence Scale-IV (for 17+ years) or the Wechsler Intelligence Scale for Children V (for 15-16 years).
• Personal history of head trauma, neurological disorder, genetic disease.
• Co-morbidities: major depressive episode or post-traumatic stress disorder unresolved or resolved within the last 6 months.
• Lack of mastery or access to a computer or personal tablet in autonomy
• Therapeutic history of metacognitive training.
• Patient under guardianship, curators or legal protection
• Patient going through a period of exacerbation of positive or negative psychotic signs likely to lead to a full-time hospitalization in a specialized environment within the next 3 months

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Lost Children Society Game; Online therapeutic role-playing session	Behavioral: Lost Children Society Game; 36 online therapeutic role-playing sessions spread over 36 weeks, one session per week

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Overall feasibility of the Game	Effective participation of the patient - feasibility will be defined by the number of effective sessions > or = 29	10 month

Collaborators and Investigators

• Sponsor: Centre Hospitalier Departemental Vendee
• Investigators: Principal Investigator: Jonathan PIONNIER, EPSM de Vendée Georges Mazurelle

Study record dates

Study Major Dates

• Study Start (Actual): April 13, 2023
• Primary Completion (Actual): November 20, 2024
• Study Completion (Actual): November 20, 2024

Study Registration Dates

• First Submitted: June 23, 2022
• First Submitted That Met QC Criteria: July 19, 2022
• First Posted (Actual): July 22, 2022

Study Record Updates

• Last Update Posted (Actual): July 22, 2025
• Last Update Submitted That Met QC Criteria: July 17, 2025
• Last Verified: July 1, 2025

More Information

Terms related to this study

• Keywords: Metacognitive Training; Early-onset Schizophrenia; Therapeutic TableTop Role Playing Game; Psychoeducational program; Lost Children Society
• Additional Relevant MeSH Terms: Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders; Schizophrenia
• Other Study ID Numbers: CHD22_0001

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No